105 related articles for article (PubMed ID: 17227883)
1. Altered promoter recycling rates contribute to dominant-negative activity of human peroxisome proliferator-activated receptor-gamma mutations associated with diabetes.
Li G; Leff T
Mol Endocrinol; 2007 Apr; 21(4):857-64. PubMed ID: 17227883
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Araki O; Ying H; Furuya F; Zhu X; Cheng SY
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.
Lüdtke A; Buettner J; Wu W; Muchir A; Schroeter A; Zinn-Justin S; Spuler S; Schmidt HH; Worman HJ
J Clin Endocrinol Metab; 2007 Jun; 92(6):2248-55. PubMed ID: 17356052
[TBL] [Abstract][Full Text] [Related]
4. Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.
Jeninga EH; van Beekum O; van Dijk AD; Hamers N; Hendriks-Stegeman BI; Bonvin AM; Berger R; Kalkhoven E
Mol Endocrinol; 2007 May; 21(5):1049-65. PubMed ID: 17312272
[TBL] [Abstract][Full Text] [Related]
5. Effect of a peroxisome proliferator-activated receptor gamma sumoylation mutant on neointimal formation after balloon injury in rats.
Lim S; Ahn BY; Chung SS; Park HS; Cho BJ; Kim M; Choi SH; Lee IK; Lee SW; Choi SJ; Chung CH; Cho YM; Lee HK; Park KS
Atherosclerosis; 2009 Oct; 206(2):411-7. PubMed ID: 19339015
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1.
Deng T; Shan S; Li PP; Shen ZF; Lu XP; Cheng J; Ning ZQ
Endocrinology; 2006 Feb; 147(2):875-84. PubMed ID: 16269451
[TBL] [Abstract][Full Text] [Related]
7. The Pal3 promoter sequence is critical for the regulation of human renin gene transcription by peroxisome proliferator-activated receptor-gamma.
Todorov VT; Desch M; Schubert T; Kurtz A
Endocrinology; 2008 Sep; 149(9):4647-57. PubMed ID: 18483152
[TBL] [Abstract][Full Text] [Related]
8. New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand.
Lüdtke A; Buettner J; Schmidt HH; Worman HJ
J Med Genet; 2007 Sep; 44(9):e88. PubMed ID: 17766367
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression.
Selva DM; Hammond GL
Endocrinology; 2009 May; 150(5):2183-9. PubMed ID: 19179433
[TBL] [Abstract][Full Text] [Related]
10. ATF3 represses PPARγ expression and inhibits adipocyte differentiation.
Jang MK; Jung MH
Biochem Biophys Res Commun; 2014 Nov; 454(1):58-64. PubMed ID: 25445599
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma.
Agostini M; Gurnell M; Savage DB; Wood EM; Smith AG; Rajanayagam O; Garnes KT; Levinson SH; Xu HE; Schwabe JW; Willson TM; O'Rahilly S; Chatterjee VK
Endocrinology; 2004 Apr; 145(4):1527-38. PubMed ID: 14657011
[TBL] [Abstract][Full Text] [Related]
13. ATF3 inhibits PPARγ-stimulated transactivation in adipocyte cells.
Jang MK; Jung MH
Biochem Biophys Res Commun; 2015 Jan; 456(1):80-5. PubMed ID: 25446101
[TBL] [Abstract][Full Text] [Related]
14. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.
Sastre M; Dewachter I; Rossner S; Bogdanovic N; Rosen E; Borghgraef P; Evert BO; Dumitrescu-Ozimek L; Thal DR; Landreth G; Walter J; Klockgether T; van Leuven F; Heneka MT
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):443-8. PubMed ID: 16407166
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter.
Gupta D; Jetton TL; Mortensen RM; Duan SZ; Peshavaria M; Leahy JL
J Biol Chem; 2008 Nov; 283(47):32462-70. PubMed ID: 18718916
[TBL] [Abstract][Full Text] [Related]
17. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
Coyle AT; O'Keeffe MB; Kinsella BT
FEBS J; 2005 Sep; 272(18):4754-73. PubMed ID: 16156795
[TBL] [Abstract][Full Text] [Related]
18. A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy.
Al-Shali K; Cao H; Knoers N; Hermus AR; Tack CJ; Hegele RA
J Clin Endocrinol Metab; 2004 Nov; 89(11):5655-60. PubMed ID: 15531525
[TBL] [Abstract][Full Text] [Related]
19. Nervous System Expression of PPARγ and Mutant PPARγ Has Profound Effects on Metabolic Regulation and Brain Development.
Stump M; Guo DF; Lu KT; Mukohda M; Cassell MD; Norris AW; Rahmouni K; Sigmund CD
Endocrinology; 2016 Nov; 157(11):4266-4275. PubMed ID: 27575030
[TBL] [Abstract][Full Text] [Related]
20. Human mannose-binding lectin 2 is directly regulated by peroxisome proliferator-activated receptors via a peroxisome proliferator responsive element.
Tachibana K; Takeuchi K; Inada H; Sugimoto K; Ishimoto K; Yamashita M; Maegawa T; Yamasaki D; Osada S; Tanaka T; Rakugi H; Hamakubo T; Sakai J; Kodama T; Doi T
J Biochem; 2013 Sep; 154(3):265-73. PubMed ID: 23711995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
